Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · 2C-I

2C-I in Saudi Arabia: not individually verified

Not individually verified

We have not confirmed that 2C-I specifically is scheduled in Saudi Arabia, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. A placement for 2C-I was not established, and the search that failed is recorded rather than summarised. The schedules attached to the Law of Combating Narcotics and Psychotropic Substances, Royal Decree M/39 of 1426 AH, in the version issued on 4 September 2026, were searched from Schedule I to Schedule IV for 2C-I and no matching entry was verified. The search record reads «سجل البحث الخاص بـ 2c-i: فُحصت الجداول من الأول إلى الرابع ولم يُتحقق من قيد مطابق.», the item specific search record for 2C-I, the schedules from the first to the fourth were examined and no matching entry was verified. What was searched: “2C-I”, “4-iodo-2,5-dimethoxyphenethylamine”, «2 سي آي»; the NBOMe compound entry and the 2C-B entry were each checked separately, and neither of them is 2C-I. That distinction is the whole of this row. 25I-NBOMe is an N-benzyl compound built on 2C-I and is not 2C-I, and 2C-B is the brominated compound; both are scheduled and neither entry names the substance on this row. Absence of a verified entry is not a finding that 2C-I is lawful in Saudi Arabia, and the schedules are kept current under M/39 Articles 70 to 71 rather than by a fresh Royal Decree.

Confirm directly with Saudi Arabia’s national drug authority or your own embassy before you rely on anything.

What Saudi Arabia HAS confirmed for related substances

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.